Evidence map›Paper›PMID 35024319›Full record

ArticleActa pharmaceutica Sinica. B2021

Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy.

Yancheng Tang, Liming Wang, Tao Yi, Jun Xu, Jigang Wang, Jiang-Jiang Qin, Qilei Chen, Ka-Man Yip, Yihang Pan, Peng Hong and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.Journal of orthopaedic surgery and research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Yancheng TangSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Liming WangSchool of Biomedical Sciences, Hunan University, Changsha 410082, China.
Tao YiSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Jun XuSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Jigang WangArtemisinin Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Jiang-Jiang QinThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.
Qilei ChenSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Ka-Man YipSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Yihang PanDepartment of Medical Research, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
Peng HongDepartment of Medical Research, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
Yingying LuDepartment of Medical Research, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
Han-Ming ShenDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Hu-Biao ChenSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR 999077, China.
Hong Kong Baptist University · HKSun Yat-sen University · CNNational University of Singapore · SGJinan University · CNZhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondria as a signaling platform play crucial roles in deciding cell fate. Many classic anticancer agents are known to trigger cell death through induction of mitochondrial damage. Mitophagy, one selective autophagy, is the key mitochondrial quality control that effectively removes damaged mitochondria. However, the precise roles of mitophagy in tumorigenesis and anticancer agent treatment remain largely unclear. Here, we examined the functional implication of mitophagy in the anticancer properties of magnolol, a natural product isolated from herbal

Indexed as

ApoptosisCombination therapyMagnololPINK1‒Parkin-mediated mitophagyTumor suppression

Identifiers

PMID35024319
PMCPMC8727919
OpenAlexW3165900319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.